GEO-CM01

N/A

Report date: 2025/02/06 16:31:47

Base Information

Drug NameGEO-CM01

Drug Alias NameSARS-COV-2 vaccine (GeoVax Labs)MUC-1 vaccine (GeoVax Labs)MVA-VLP cancer vaccine (Geovax Labs)Wuhan coronavirus (2019-nCoV) vaccine (GeoVax Labs)GEO-CM01 +[7]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGeovax Labs Inc

China Registration ClassN/A

Develop Information

Active CompaniesGeovax Labs Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A